Results

Total Results: 1,077 records

Showing results for "phase".

  1. effectivehealthcare-admin.ahrq.gov/products/fecal-incontinence/research-protocol
    December 01, 2019 - blind method/ (124975) single blind method/ (18853) clinical trial/ (486017) clinical trial, phase … i.pt. (13981) clinical trial, phase ii.pt. (22475) clinical trial, phase iii.pt. (8783) clinical … trial, phase iv.pt. (921) controlled clinical trial.pt. (88103) randomized controlled trial.pt.
  2. effectivehealthcare-admin.ahrq.gov/products/fibromyalgia/research-protocol
    December 01, 2019 - blind method/ (131905) single blind method/ (19625) clinical trial/ (504861) clinical trial, phase … i.pt. (16220) clinical trial, phase ii.pt. (26918) clinical trial, phase iii.pt. (10181) clinical … trial, phase iv.pt. (997) controlled clinical trial.pt. (89925) randomized controlled trial.pt.
  3. effectivehealthcare-admin.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
    May 01, 2019 - blind method/ (159463) single blind method/ (27137) clinical trial/ (553719) clinical trial, phase … i.pt. (20676) clinical trial, phase ii.pt. (33325) clinical trial, phase iii.pt. (15646) clinical … trial, phase iv.pt. (1673) controlled clinical trial.pt. (100423) randomized controlled trial.pt
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/telehealth-during-COVID-19-amendments.pdf
    April 28, 2022 - Each of these considerations had been discussed with the stakeholders during the topic refinement phase … : the era of COVID-19 (March 2020-present) KQ1d: During the first 4 months or beyond the initial phase … the era of COVID-19 (March 2020-present) KQ1d: During the first 4 months or beyond the initial phase … 20 Appendix A: Cost Outcomes Infrastructure Cost of implementation and sustaining phase
  5. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - also excluded patients who did not meet minimum response criteria or were nonadherent during a run-in phase … before the double-blind treatment phase.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
    November 03, 2014 - The acute phase is self-limited and characterized by recurrent attacks of synovitis (articular inflammation … 1ß-inhibitory anti- inflammatory agents currently approved for treatment of rheumatoid arthritis and in Phase
  7. S44 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s44.pdf
    October 01, 2007 - ORIGINAL ARTICLE Designed Delays Versus Rigorous Pragmatic Trials Lower Carat Gold Standards Can Produce Relevant Drug Evaluations Malcolm Maclure, ScD,* Bruce Carleton, PharmD,† and Sebastian Schneeweiss, MD, ScD‡§¶ Background: Centralized administrative databases enable low-cost pragmatic randomized trials (PRTs) …
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/innovations_in_stakeholder_engagement_conference_summary2.pdf
    October 01, 2011 - Innovations in Stakeholder Engagement Conference Summary Innovations in Stakeholder Engagement Conference Summary 2 AHRQ Community Forum Overview of Types of Online Collaborative Platforms Chris Haller, Founder and CEO, Urban Interactive Studios Online collaborative platforms provide an avenue for individua…
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
    May 01, 2017 - KQ4: What is the evidence that effects measured at the end of the treatment phase predict long-term … investigative team also scanned the reference lists of studies included after the full-text review phase … atomoxetine No serious adverse events reported; most harms attenuated over open label extension phase
  10. Ced-Appendix-3 (xls file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ced-appendix-3.xlsx
    June 24, 2022 - NICE_cancer Data Use data from a registry, from ongoing studies (for example, further follow-up of Phase … II and III trials, or Phase IV or pharmacovigilance studies), or set up new data collection. … NICE_cancer Data_source Use data from a registry, from ongoing studies (for example, further follow-up of Phase … II and III trials, or Phase IV or pharmacovigilance studies), or set up new data collection.
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/krishnan_ahrq-mcda-presentation.pdf
    August 27, 2012 - PowerPoint Presentation Use of Analytic Hierarchy Process to elicit stakeholder preferences for prioritizing research August 27, 2012 Jerry A. Krishnan, MD, PhD (jakris@uic.edu) Professor of Medicine and Public Health Associate Vice President for Population Health Sciences on behalf of the CONCERT …
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-protocol.pdf
    April 17, 2024 - These forms will be refined through a pilot phase involving a small set of studies to ensure they adequately … Syndikus I, Griffin C, Philipps L, et al. 10-Year efficacy and co-morbidity outcomes of a phase III … radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - While one Phase 2 trial and one Phase 3 trial were both able to show a reduction in bleeding with the … A case in point is the recently published Novo Nordisk sponsored Phase 2 cardiac trial (F7CARD-1610) … The pooling of dose-escalation studies with Phase 2 or Phase 3 studies in the efficacy analyses is a … non-parallel safety studies (Mayer 2005b31 and Mayer 200632) are inappropriately combined with the Phase … Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. .Neurocrit
  14. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … Liraglutide is under investigation for obesity treatment in a four-part, phase III clinical trial ( … People with type 2 diabetes achieve 6% weight loss with liraglutide 3 mg in phase 3a obesity trial … Novo Nordisk reports 8% weight loss in phase 3a obesity trial with liraglutide 3 mg.
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
    September 02, 2016 - $$$randomized$controlled$trial/$(416302)$ 11$$$$$clinical$trial/$(500056)$ 12$$$$$clinical$trial,$phase … $i.pt.$(16112)$ 13$$$$$clinical$trial,$phase$ii.pt.$(26010)$ 14$$$$$clinical$trial,$phase$iii.pt.$( … 11141)$ 15$$$$$clinical$trial,$phase$iv.pt.$(1169)$ 16$$$$$controlled$clinical$trial.pt.$(90707)$ … $Electromyogram"lengthening$velocity$relation$in$ plantar$flexors$during$stance$phase$of$gait$in$patients … $The$Relationship$of$Health$Locus$ of$Control$and$Health"Related$Quality$of$Life$in$the$Chronic$Phase
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
    October 01, 2014 - A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit … A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit … We found one-long term (72 weeks) RCT reporting on the maintenance phase (Findling, 2012). … One completed suicide occurred during the OLE phase. … A phase 2a randomized, parallel group, dose-ranging study of molindone in children with attention-deficit
  17. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-different-models-of-survivorship-care-and-sets-of-services-on-late-and-long-term-net-health-outcomes-eg-for-breast-cancer
    November 01, 2017 - The focus on survivorship as a distinct phase of the cancer continuum is important to ensure that these
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists three topics for which (1) preliminary or published phase III data were … medication regimens tested in clinical trials has been implicated as a significant reason that many phase … Failure to determine these thresholds during Phase 2 is believed to be one of the main reasons for … Phase 3 failures.”30 One phase IV clinical trial is ongoing to evaluate the cost and perception of
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-app-f.xlsx
    January 01, 2019 - Unclear No Yes (CROs) No (PROs) Yes No No Unclear Unclear Unclear Yes Poor Sprave, 2018 Randomized phase
  20. #05 DEPRESSION (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the three topics for which (1) preliminary mid- or late-phase data for … topics in this priority area were eligible for consideration for high-impact potential because no phase … indication, and Janssen plans to also apply for breakthrough therapy status.38,39 Janssen has two new phase … that all available scopolamine formulations had some degree of antidepressant efficacy.75 In the phase

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: